Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 25.01
+0.28 (1.13%)
Feb 4, 2026, 3:04 PM CST
Dian Diagnostics Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -431.43 | -357.28 | 307.46 | 1,434 | 1,163 | 802.93 |
Depreciation & Amortization | 595.04 | 595.04 | 691.44 | 799.5 | 494.73 | 292.91 |
Other Amortization | 130.75 | 130.75 | 100.53 | 89.14 | 75.17 | 72.78 |
Loss (Gain) From Sale of Assets | 1.48 | 1.48 | 3.57 | 11.18 | -6.35 | 0.08 |
Asset Writedown & Restructuring Costs | 391.11 | 391.11 | 25.72 | 831.79 | 21.53 | 447.86 |
Loss (Gain) From Sale of Investments | -9.99 | -9.99 | 18.32 | 7.45 | 124.89 | -60.32 |
Provision & Write-off of Bad Debts | 444.55 | 444.55 | 375.75 | 298.49 | 91.32 | 89.84 |
Other Operating Activities | 1,327 | 435.25 | 548.8 | 744.02 | 553.48 | 494.62 |
Change in Accounts Receivable | 139.29 | 139.29 | 1,969 | -4,152 | -2,030 | 353.08 |
Change in Inventory | -139.6 | -139.6 | 55.57 | -90.93 | -223.04 | 236.91 |
Change in Accounts Payable | -289.66 | -289.66 | -2,065 | 1,524 | 1,025 | -1,165 |
Change in Other Net Operating Assets | -3.92 | -3.92 | 13.84 | 58.6 | 121.93 | 13.88 |
Operating Cash Flow | 2,025 | 1,207 | 1,921 | 1,639 | 1,318 | 1,547 |
Operating Cash Flow Growth | 25.87% | -37.16% | 17.20% | 24.39% | -14.82% | 220.21% |
Capital Expenditures | -353.51 | -363.19 | -701.77 | -947.72 | -589.5 | -475.71 |
Sale of Property, Plant & Equipment | 5.95 | 9.73 | 22.03 | 14.76 | 24.59 | 18.24 |
Cash Acquisitions | -17.03 | -16.98 | -60.93 | -64.59 | -41.5 | -29.79 |
Divestitures | 63.42 | 88.59 | -13.07 | 0.32 | 0.85 | 0.19 |
Investment in Securities | 71.07 | -256.29 | 57.45 | -159.75 | -4.5 | -335.47 |
Other Investing Activities | -5.89 | 2.9 | 9.55 | 84.56 | 73.84 | 1.8 |
Investing Cash Flow | -235.99 | -535.24 | -686.74 | -1,072 | -536.22 | -820.74 |
Long-Term Debt Issued | - | 1,912 | 2,074 | 6,032 | 4,997 | 4,091 |
Total Debt Issued | 1,718 | 1,912 | 2,074 | 6,032 | 4,997 | 4,091 |
Long-Term Debt Repaid | - | -2,635 | -4,366 | -4,661 | -5,095 | -3,875 |
Total Debt Repaid | -2,889 | -2,635 | -4,366 | -4,661 | -5,095 | -3,875 |
Net Debt Issued (Repaid) | -1,170 | -722.99 | -2,292 | 1,371 | -97.05 | 216.11 |
Issuance of Common Stock | - | - | - | 158.32 | - | - |
Repurchase of Common Stock | -199.57 | -199.57 | -40.96 | -9.03 | - | - |
Common Dividends Paid | -257.19 | -575.71 | -300.62 | -296.9 | -266.12 | -261.54 |
Other Financing Activities | -173.1 | -336.04 | 200.59 | 204.47 | 53.17 | -210.95 |
Financing Cash Flow | -1,800 | -1,834 | -2,433 | 1,428 | -309.99 | -256.37 |
Foreign Exchange Rate Adjustments | 5.46 | 2.32 | 1.2 | 6.88 | -3.73 | -7.63 |
Net Cash Flow | -5.74 | -1,160 | -1,197 | 2,002 | 467.97 | 462.49 |
Free Cash Flow | 1,671 | 844.2 | 1,220 | 691.64 | 728.42 | 1,072 |
Free Cash Flow Growth | 51.23% | -30.78% | 76.33% | -5.05% | -32.02% | 1394.69% |
Free Cash Flow Margin | 15.91% | 6.92% | 9.10% | 3.41% | 5.57% | 10.06% |
Free Cash Flow Per Share | 2.73 | 1.37 | 1.95 | 1.11 | 1.17 | 1.72 |
Cash Income Tax Paid | 502.48 | 566.37 | 843.93 | 1,017 | 707.36 | 452.24 |
Levered Free Cash Flow | 1,917 | 878.06 | 587.88 | -251.96 | -461.53 | 1,112 |
Unlevered Free Cash Flow | 2,015 | 1,005 | 744.51 | -80.26 | -317.65 | 1,241 |
Change in Working Capital | -423.51 | -423.51 | -150.25 | -2,576 | -1,200 | -593.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.